A randomised control trial to compare the efficacy of online exposure-based CBT versus multi-component CBT for reducing symptoms of panic disorder and agoraphobia in adults.

niversity of New South Wales0 个研究点目标入组 70 人开始时间: 2018年9月6日最近更新: 2020年12月7日

适应症

试验速览

暂无简介。

•Self-identified as experiencing panic and/or anxiety.
•- Meet DSM-5 criteria for panic (with or without comorbid agoraphobia) as assessed by ADIS-5 for DSM-5.
•- At least 18 years of age
•- Live in Australia
•- Fluent in English
•- Have access to a computer that is connected to the internet
•- Currently under the care of a General Practitioner (have seen GP in last 3 months for any reason; able to provide contact details for GP so a letter can be sent informing GP that patient is enrolled in the study).
•- If taking medication, must have been taking the same dose for at least 8 weeks and not intend to change that dose during the course of the program.
•- Prepared to provide name, phone number, and address.
•- Willing to provide informed consent.

•- Does not meet criteria for panic disorder
•- Self-reported diagnosis of schizophrenia, bipolar disorder or current psychotic symptoms
•- Regularly using illicit drugs or regularly consuming more than three standard drinks per day (substance dependence)
•- Taking benzodiazepines on a daily basis
•- Severe depressive symptoms (score of 23 or above on the PHQ-9)
•- Current suicidal ideation (defined as responding 3 to the PHQ-9 question 9 item that assesses the frequency of suicidal ideation, and/or responding greater than 1 on the BDI-II suicide item)
•-Those scoring 1 or 2 on the Patient Health Questionnaire-9 Item (PHQ-9) item 9 will require a risk assessment with a study clinician before being admitted into the study.
•- Changed medication dosage (including starting new medication) within the past 8 weeks.
•- Currently participating in Cognitive Behavioural Therapy.
•- Do not complete the online screening questionnaire or unwilling to provide demographic details

发起方